Vasilios G Athyros Selected Research

Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)

1/2022	Clinical benefit of statin treatment on patients with non-alcoholic fatty liver disease or steatohepatitis.
7/2021	Rosuvastatin and ezetimibe for the treatment of dyslipidemia and hypercholesterolemia.
1/2021	Long-term statin treatment for hepatic fibrosis in patients with nonalcoholic fatty liver disease: Is it time to give the emperor a statin robe?
1/2021	Statins and Non-Alcoholic Fatty Liver Disease Progression: Further Comments.
1/2021	Prevalence, Diagnosis, and Treatment with 3 Different Statins of Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role?
10/2020	NAFLD and Statins.
1/2020	Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block.
1/2019	What Does the Future Hold for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis?
4/2018	The potential role of statins in treating liver disease.
3/2018	Diabetes and lipid metabolism.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vasilios G Athyros Research Topics

Disease

36	Non-alcoholic Fatty Liver Disease 01/2022 - 05/2006
31	Cardiovascular Diseases (Cardiovascular Disease) 07/2021 - 01/2006
27	Coronary Disease (Coronary Heart Disease) 01/2018 - 01/2002
22	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 08/2005
20	Hypertension (High Blood Pressure) 03/2022 - 01/2002
19	Type 2 Diabetes Mellitus (MODY) 11/2021 - 07/2002
15	Heart Failure 11/2021 - 01/2002
15	Stroke (Strokes) 01/2019 - 01/2002
14	Atherosclerosis 03/2022 - 01/2002
13	Obesity 03/2022 - 08/2005
13	Dyslipidemias (Dyslipidemia) 07/2021 - 11/2003
13	Alcoholic Fatty Liver 01/2021 - 08/2012
12	Diabetes Mellitus 01/2017 - 01/2002
11	Inflammation (Inflammations) 03/2022 - 05/2006
11	Chronic Renal Insufficiency 11/2021 - 07/2009
8	Insulin Resistance 03/2022 - 04/2005
8	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 10/2004
8	Vascular Diseases (Vascular Disease) 01/2016 - 11/2004
5	Hyperlipidemias (Hyperlipidemia) 01/2015 - 07/2002
4	Fatty Liver 01/2022 - 01/2018
4	Weight Loss (Weight Reduction) 01/2019 - 05/2007
4	Acute Coronary Syndrome 02/2015 - 01/2009
4	Unstable Angina 09/2013 - 01/2002
4	Abdominal Obesity 01/2010 - 11/2005
3	Hypercholesterolemia 07/2021 - 02/2008
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 01/2017
3	Fibrosis (Cirrhosis) 01/2021 - 01/2018
3	Ischemic Stroke 12/2018 - 01/2009
3	Liver Diseases (Liver Disease) 04/2018 - 02/2014
3	Hyperaldosteronism (Conn Syndrome) 01/2018 - 03/2008
3	Body Weight (Weight, Body) 01/2018 - 05/2006
3	Thrombosis (Thrombus) 01/2018 - 11/2010
3	Neoplasms (Cancer) 01/2017 - 12/2007
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2016 - 07/2014
3	Crohn Disease (Crohn's Disease) 01/2016 - 07/2014
3	Ulcerative Colitis 01/2016 - 07/2014
3	Atherosclerotic Plaque (Atheroma) 01/2015 - 03/2007
3	Essential Hypertension 02/2014 - 09/2006
3	Obstructive Sleep Apnea 01/2014 - 01/2014
3	Myocardial Infarction 09/2013 - 11/2007
3	Necrosis 01/2013 - 01/2010
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2022 - 07/2020
2	Overweight 03/2022 - 01/2015
2	Diabetes Complications 11/2021 - 01/2014
2	Hepatocellular Carcinoma (Hepatoma) 04/2018 - 01/2018
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2018 - 07/2002
2	Peripheral Arterial Disease 01/2018 - 06/2005
2	Vascular Calcification 01/2016 - 04/2008
2	Alcoholism (Alcohol Abuse) 07/2015 - 02/2014

Drug/Important Bio-Agent (IBA)

79	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 02/2002
35	Atorvastatin (Lipitor)FDA Link 07/2021 - 01/2002
29	LipidsIBA 07/2021 - 01/2002
15	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 08/2005
15	oxidized low density lipoproteinIBA 03/2018 - 01/2002
15	LDL CholesterolIBA 03/2018 - 01/2002
15	Uric Acid (Urate)IBA 01/2018 - 04/2004
13	Pharmaceutical PreparationsIBA 11/2021 - 07/2002
12	Triglycerides (Triacylglycerol)IBA 03/2018 - 11/2005
10	CholesterolIBA 04/2014 - 01/2002
9	HDL CholesterolIBA 03/2018 - 05/2004
8	Rosuvastatin Calcium (Crestor)FDA Link 07/2021 - 07/2009
7	AdipokinesIBA 03/2022 - 01/2010
7	Fibric Acids (Fibrates)IBA 03/2018 - 02/2002
6	Ezetimibe (Zetia)FDA Link 07/2021 - 02/2008
6	C-Reactive ProteinIBA 01/2015 - 05/2006
5	Pioglitazone (Actos)FDA Link 01/2020 - 01/2017
5	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2020 - 01/2016
5	Antihypertensive Agents (Antihypertensives)IBA 12/2018 - 02/2007
5	EnzymesIBA 01/2018 - 12/2010
5	MicroRNAs (MicroRNA)IBA 01/2017 - 01/2014
4	AdiponectinIBA 10/2018 - 05/2007
4	Vitamin D FDA LinkGeneric 05/2014 - 09/2010
4	Simvastatin (Zocor)FDA LinkGeneric 01/2013 - 01/2003
3	Blood Glucose (Blood Sugar)IBA 11/2021 - 11/2005
3	Drug CombinationsIBA 07/2021 - 01/2011
3	Insulin (Novolin)FDA Link 07/2020 - 05/2006
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2020 - 01/2018
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020 - 01/2017
3	SodiumIBA 01/2019 - 01/2016
3	Losartan (Cozaar)FDA LinkGeneric 01/2018 - 01/2006
3	Trinitrotoluene (TNT)IBA 01/2018 - 05/2005
3	Proprotein Convertase 9IBA 01/2018 - 01/2015
3	Biomarkers (Surrogate Marker)IBA 01/2015 - 04/2005
3	aliskiren FDA Link 02/2014 - 04/2007
3	Atenolol (Tenormin)FDA LinkGeneric 02/2014 - 09/2006
3	CytokinesIBA 01/2014 - 01/2014
3	Fenofibrate (CiL)FDA LinkGeneric 06/2008 - 07/2002
2	Metformin (Glucophage)FDA LinkGeneric 11/2021 - 05/2006
2	Sodium-Glucose Transport ProteinsIBA 11/2021 - 01/2018
2	Vitamin E FDA LinkGeneric 01/2020 - 01/2018
2	IronIBA 01/2020 - 02/2009
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2019 - 01/2016
2	AldosteroneIBA 10/2018 - 09/2008
2	Spironolactone (Aldactone)FDA LinkGeneric 01/2018 - 03/2008
2	Hypolipidemic Agents (Antihyperlipidemics)IBA 01/2018 - 01/2018
2	CanagliflozinIBA 11/2017 - 10/2016
2	Transaminases (Aminotransferases)IBA 10/2015 - 02/2002

Therapy/Procedure

19	Therapeutics 01/2020 - 06/2005
8	Secondary Prevention 12/2018 - 01/2006
6	Percutaneous Coronary Intervention 01/2016 - 04/2010